Twitter | Pretraživanje | |
Certara
Certara is the global leader in advancing modern, efficient drug development.
2.393
Tweetovi
596
Pratim
991
Osobe koje vas prate
Tweetovi
Certara 22 h
Looking for a new opportunity? Click here to explore some of our latest hot :
Reply Retweet Označi sa "sviđa mi se"
Certara 1. velj
Join the Certara team! We have exciting opportunities to work with hundreds of biopharmaceutical companies, leading academic institutions, and key regulatory agencies worldwide! Find a position that fits you here:
Reply Retweet Označi sa "sviđa mi se"
Certara 1. velj
Certara is hiring an Associate Scientist within our Strategic Consulting division! This position will be based in - Learn more:
Reply Retweet Označi sa "sviđa mi se"
Certara 31. sij
- Demonstrating bioequivalence (BE) with Certara’s Simcyp MechDermA Model. Read here:
Reply Retweet Označi sa "sviđa mi se"
Certara 30. sij
Join our new 3-day classroom course that teaches students to go beyond NCA! Learn to model and simulate individual and population data. Session coming up 24-26 March 2020 in . To learn more and register, visit
Reply Retweet Označi sa "sviđa mi se"
Certara proslijedio/la je tweet
BaseCase Interactive 28. sij
As competition for increasingly constrained healthcare budgets continues to rise, learn about some of the most common tools and field teams are using to secure market access:
Reply Retweet Označi sa "sviđa mi se"
Certara 28. sij
Don't miss out on our first webinar of 2020! Tomorrow we will present, "Updates to the Simcyp Simulator’s Oral Absorption ADAM and M-ADAM Models." Register now:
Reply Retweet Označi sa "sviđa mi se"
Certara 27. sij
[2/13 Webinar] We'll discuss how pricing has evolved from the 1990s to today for the rare disease drug market and much more! Register here:
Reply Retweet Označi sa "sviđa mi se"
Certara 24. sij
Certara University is offering LIVE online classroom course focused on learning Noncompartmental analysis (NCA) using Phoenix WinNonlin. To learn more and register, visit
Reply Retweet Označi sa "sviđa mi se"
Certara 23. sij
Free! A compilation of Certara’s biggest challenges and accomplishments in model-informed drug development, health economics/outcomes research and real world evidence, and regulatory science, strategy, and services. To download the blog book, visit
Reply Retweet Označi sa "sviđa mi se"
Certara proslijedio/la je tweet
F1000Research 22. sij
Precision medicine - a reality or just hype? In this opinion article, the authors from , , and , provide a overview of precision medicine using model-informed precision dosing as an example 👉
Reply Retweet Označi sa "sviđa mi se"
Certara 23. sij
- More than 90% of novel new drug approvals by the US Food and Drug Administration () in 2019 were supported by Certara or services. To read the full press release, visit
Reply Retweet Označi sa "sviđa mi se"
Certara proslijedio/la je tweet
Synchrogenix 22. sij
Global Head of Transparency & Disclosure, , delving in to prospective & retrospective analyses of clinical disclosure & data sharing requirements.
Reply Retweet Označi sa "sviđa mi se"
Certara 22. sij
[1/29 Webinar] Learn about recent additions to the ADAM/M-ADAM mechanistic models in version 19 of the Simcyp Population-based PBPK Simulator. Register here:
Reply Retweet Označi sa "sviđa mi se"
Certara 17. sij
This week's post discusses strategies for supporting value-based drug pricing! Read it here:
Reply Retweet Označi sa "sviđa mi se"
Certara 13. sij
Meet with some of Certara’s subject matter experts at ! We're excited to be here and showcase how Certara is changing the game in drug development and patient access. To learn more about us, visit
Reply Retweet Označi sa "sviđa mi se"
Certara 11. sij
Join the Certara team! We have exciting opportunities to work with hundreds of biopharmaceutical companies, leading academic institutions, and key regulatory agencies worldwide! Find a position that fits you here:
Reply Retweet Označi sa "sviđa mi se"
Certara 10. sij
- Guest writer Leticia Arrington from Merck explores how utilizing model-based meta-analysis () methodologies can support the future development of novel drugs to treat DPN, PHN, and fibromyalgia. Read here:
Reply Retweet Označi sa "sviđa mi se"
Certara proslijedio/la je tweet
BaseCase Interactive 9. sij
Learn from our VP of Consulting, Atlanta Kassatly, how our consultants utilize their expertise to provide innovative, data-driven mobile apps to clients. Read more:
Reply Retweet Označi sa "sviđa mi se"
Certara 9. sij
Certara University is pleased to announce a new class focused on learning NCA using Phoenix WinNonlin. This class will be offered as a LIVE online classroom course. To learn more and register, visit
Reply Retweet Označi sa "sviđa mi se"